target directory

amifampridine phosphate 3 4 diaminopyridine phosphate acts as a potassium channel blocker enhancing the release of acetylcholine at the neuromuscular junction thereby improving neuromuscular transmission clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.